HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antioxidant disclaimers

This article was originally published in The Tan Sheet

Executive Summary

"FDA has determined that although some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer, this evidence is limited and not conclusive," reads one acceptable disclaimer crafted to accompany antioxidant health claim, agency tells Durk Pearson et al. in April 6 letter. Washington, D.C. federal court Judge Gladys Kessler directed FDA to permit the claim "consumption of antioxidant vitamins may reduce the risk of certain kinds of cancer" in a Dec. 26 opinion (1"The Tan Sheet" Jan. 6, 2003, p. 15). FDA has developed two other similar disclaimers that companies may use when opting to run the new health claim...

"FDA has determined that although some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer, this evidence is limited and not conclusive," reads one acceptable disclaimer crafted to accompany antioxidant health claim, agency tells Durk Pearson et al. in April 6 letter. Washington, D.C. federal court Judge Gladys Kessler directed FDA to permit the claim "consumption of antioxidant vitamins may reduce the risk of certain kinds of cancer" in a Dec. 26 opinion (1 (Also see "FDA Antioxidants/Cancer Risk Reduction Claim Ban Found Unconstitutional" - Pink Sheet, 6 Jan, 2003.), p. 15). FDA has developed two other similar disclaimers that companies may use when opting to run the new health claim....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS128962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel